The PTX/siRNA@TGN/RGD-HBc VLPs effectively targeted the brain and resulted in more tumor growth inhibition than PTX@TGN/RGD-HBc VLPs and saline in orthotopic U87-Luci tumor-bearing mice. Here, KRT88P is linked to neoplasm.